Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ANEB will decline by -50.66% over the next 2 Weeks and hit $0.23 by Friday, March 6, 2026. In that time frame, ANEB's share price is expected to range between $0.07 and $0.39.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 6, 2026 | 0.09 | 0.25 | 0.40 |
| Mar 5, 2026 | 0.14 | 0.29 | 0.46 |
| Mar 4, 2026 | 0.11 | 0.28 | 0.45 |
| Mar 3, 2026 | 0.18 | 0.32 | 0.49 |
| Mar 2, 2026 | 0.19 | 0.35 | 0.51 |
| Feb 27, 2026 | 0.22 | 0.36 | 0.51 |
| Feb 26, 2026 | 0.25 | 0.40 | 0.56 |
| Feb 25, 2026 | 0.23 | 0.39 | 0.56 |
| Feb 24, 2026 | 0.27 | 0.43 | 0.59 |
| Feb 23, 2026 | 0.30 | 0.46 | 0.62 |
ANEB shares fell -2.13% in Friday, February 20, 2026's trading session, dropping from a previous close of $0.48 to move at $0.47. The stock demonstrated notable intraday movement (see ANEB's key stats for a full breakdown), fluctuating between $0.45 and $0.48, a +6.63% trading range. While recent weeks have seen some volatility, ANEB has managed to secure a -5.49% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 121.72K shares changing hands, 56.76K more than the previous session. This amounted to $57.57K in total market activity.
Will ANEB Continue Its Downward Trend?
According to analyst ratings and projections for ANEB, Anebulo Pharmaceuticals, Inc. shares are anticipated to decrease by -17.56%, potentially reaching $0.40 per share by March 6, 2026. Short-term technical indicators for ANEB currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 20 negative trading days within the past 30 sessions. Based on the ANEB stock forecast, now is not the best time to buy ANEB stock because its current trading price is +90.88% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ANEB covering social and institutional perspectives.
ANEB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ANEB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 19.11% to 23.98%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 32.98%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 40.66%, maintains a neutral outlook for the long term. Insights into ANEB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Anebulo Pharmaceuticals Short-Term Forecasts
ANEB Forecast For Next 5 Days
Our algorithm anticipates Anebulo Pharmaceuticals (ANEB) stock could hit $0.28 by Feb 27, 2026. This represents a -40.40% fall from today's price, following a -3.54% change over the past five days.
ANEB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Anebulo Pharmaceuticals, Inc. (ANEB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.29, which would mean a -38.69% decrease from the current price of $0.47. Projections for this period range from a high of $0.71 to a low of $0.00.
ANEB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Anebulo Pharmaceuticals's price over the next three months point to a rise. ANEB stock is expected to peak at $3.90 on Mar 06, 2026 before potentially dipping to $1.47 on May 11, 2026. On average, ANEB is likely to trade around $2.56 in the coming 90 days.
Anebulo Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Anebulo Pharmaceuticals (ANEB) is expected to trade between $0.00 and $4.78 throughout 2026. This would result in an average price of $2.85, potentially offering investors a +502.54% return from current levels.
Anebulo Pharmaceuticals, Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Anebulo Pharmaceuticals, Inc. (ANEB) is positioned to show a strong performance in February 2026. The price is predicted to move between $3.12 and $3.53, settling at an average of $3.32. This could translate to a +601.90% gain.
March 2026
Based on current market signals, Anebulo Pharmaceuticals, Inc. is projected to trend march 2026. We forecast a trading range from $2.31 to $3.90, with a likely average price of $3.33. Investors could expect a potential return of +604.02%.
April 2026
Our predictive algorithms indicate Anebulo Pharmaceuticals, Inc. stock may see a shift in April 2026. The expected range spans $1.80–$2.47, with an average target of $2.13. This represents a positive outlook and a possible gain of +350.32%.
May 2026
Analyzing established trends, Anebulo Pharmaceuticals, Inc. looks set to move in May 2026. Projections place the stock between $1.47 and $2.32, averaging around $1.88. This suggests a +297.46% gain from current levels.
June 2026
Market indicators suggest Anebulo Pharmaceuticals, Inc. could experience notable changes during June 2026. Prices could fluctuate within $1.09 to $1.98, with a midpoint forecast of $1.60. The stock might deliver a +238.27% gain.
July 2026
Forecasting for July 2026, models estimate that Anebulo Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.02 and $3.81, averaging $2.19. This signals a positive trajectory with potential returns around +363.00%.
August 2026
According to our latest forecast models, Anebulo Pharmaceuticals, Inc. (ANEB) is positioned to show a strong performance in August 2026. The price is predicted to move between $1.90 and $4.44, settling at an average of $3.95. This could translate to a +735.10% gain.
September 2026
Based on current market signals, Anebulo Pharmaceuticals, Inc. is projected to trend september 2026. We forecast a trading range from $1.76 to $4.72, with a likely average price of $4.12. Investors could expect a potential return of +771.04%.
October 2026
Our predictive algorithms indicate Anebulo Pharmaceuticals, Inc. stock may see a shift in October 2026. The expected range spans $0.68–$4.78, with an average target of $4.36. This represents a positive outlook and a possible gain of +821.78%.
November 2026
Analyzing established trends, Anebulo Pharmaceuticals, Inc. looks set to move in November 2026. Projections place the stock between $0.00 and $3.88, averaging around $3.09. This suggests a +553.28% gain from current levels.
December 2026
Market indicators suggest Anebulo Pharmaceuticals, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $2.13, with a midpoint forecast of $1.79. The stock might deliver a +278.44% gain.
January 2027
Forecasting for January 2027, models estimate that Anebulo Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.80, averaging $1.48. This signals a positive trajectory with potential returns around +212.90%.
February 2027
According to our latest forecast models, Anebulo Pharmaceuticals, Inc. (ANEB) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $1.15, settling at an average of $0.96. This could translate to a +102.96% gain.
ANEB's history of dividends and stock splits also plays a role in long-term investor confidence.

